Serosal Invasion Strongly Associated with Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma: a Retrospective Study of 214 Consecutive Cases

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2015 Mar 5

PMID 25738484

Citations 5

Authors

Fuminori Sonohara

Shuji Nomoto

Yoshikuni Inokawa

Mitsuro Kanda

Suguru Yamada

Tsutomu Fujii

Hiroyuki Sugimoto

Yasuhiro Kodera

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to clarify the individual prognostic factors after curative and primary resection of hepatocellular carcinoma (HCC).Reliable prognostic factors and tumor staging for HCC have been required to predict an appropriate prognosis. However, in HCC, no staging system has received universal acceptance, and several tumor factors seem to relate to HCC prognosis, but they are not definitive. At present, few studies have mentioned the importance of serosal invasion as a prognostic factor.A retrospective search of our database identified 214 consecutive patients who underwent primary and curative hepatectomy for HCC at our department between January 1998 and December 2011. Risk factors for recurrence-free survival (RFS) and overall survival (OS) were analyzed with Cox proportional hazard model, Kaplan-Meier method, and log-rank tests.Multivariate analyses showed that serosal invasion (hazard ratio [HR], 2.75; P = 0.0005) and vascular invasion (HR, 1.71; P = 0.0331) were independently correlated with RFS. Serosal invasion was significantly correlated with HCC recurrence (P = 0.0230). The Kaplan-Meier method and log-rank tests revealed that the patients with serosal invasion showed significantly worse prognosis both in RFS (P < 0.0001) and OS (P = 0.0016).Serosal invasion should be regarded as a strong independent predictor for recurrence in curatively resected HCC cases.

Citing Articles

Liver resection in patients with a history of local ablation for hepatocellular carcinoma has the risk of poor survival and serosal invasion.

Nishi Y, Sakamoto K, Uraoka M, Nagaoka T, Honjo M, Tamura K Ann Gastroenterol Surg. 2025; 9(2):347-358.

PMID: 40046521 PMC: 11877331. DOI: 10.1002/ags3.12872.

Prognostic Role of the Intrahepatic Lymphatic System in Liver Cancer.

Sakamoto K, Ogawa K, Tamura K, Honjo M, Funamizu N, Takada Y Cancers (Basel). 2023; 15(7).

PMID: 37046803 PMC: 10093457. DOI: 10.3390/cancers15072142.

Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis.

Orimo T, Kamiyama T, Wakayama K, Shimada S, Nagatsu A, Asahi Y Ann Surg Oncol. 2020; 27(11):4153-4163.

PMID: 32588266 DOI: 10.1245/s10434-020-08754-6.

Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation.

Umetsu S, Mizukami H, Saito T, Uchida C, Igawa A, Kudo K Sci Rep. 2020; 10(1):1156.

PMID: 31980687 PMC: 6981134. DOI: 10.1038/s41598-020-57883-1.

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.

Jin Y, Wong Y, Goh B, Chan C, Cheow P, Chow P Sci Rep. 2019; 9(1):10464.

PMID: 31320713 PMC: 6639394. DOI: 10.1038/s41598-019-46872-8.

References

Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y . Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006; 244(2):265-73. PMC: 1602154. DOI: 10.1097/01.sla.0000217921.28563.55. View

Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T . Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993; 105(2):488-94. DOI: 10.1016/0016-5085(93)90724-q. View

Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K . Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer. 1996; 77(10):2022-31. DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S. View

Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H . Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996; 83(9):1219-22. View

Nzeako U, Goodman Z, Ishak K . Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol. 1996; 105(1):65-75. DOI: 10.1093/ajcp/105.1.65. View

Trutmann M, Sasse D . The lymphatics of the liver. Anat Embryol (Berl). 1994; 190(3):201-9. DOI: 10.1007/BF00234299. View

Kobayashi A, Kawasaki S, Miyagawa S, Miwa S, Noike T, Takagi S . Results of 404 hepatic resections including 80 repeat hepatectomies for hepatocellular carcinoma. Hepatogastroenterology. 2006; 53(71):736-41. View

Ng I, Lai E, Ng M, Fan S . Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer. 1992; 70(1):45-9. DOI: 10.1002/1097-0142(19920701)70:1<45::aid-cncr2820700108>3.0.co;2-7. View

Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H . Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 1993; 71(1):19-25. DOI: 10.1002/1097-0142(19930101)71:1<19::aid-cncr2820710105>3.0.co;2-i. View

10.

Szabo G, Magyar Z, Jakab F . The lymphatic drainage of the liver capsula and hepatic parenchyma. Res Exp Med (Berl). 1975; 166(2):193-200. DOI: 10.1007/BF01851185. View

11.

Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J . Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol. 2001; 96(4):1243-50. DOI: 10.1111/j.1572-0241.2001.03634.x. View

12.

Vauthey J, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L . Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995; 169(1):28-34; discussion 34-5. DOI: 10.1016/s0002-9610(99)80106-8. View

13.

Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K . Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995; 108(3):768-75. DOI: 10.1016/0016-5085(95)90450-6. View

14.

Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S . Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology. 1993; 40(4):328-32. View

15.

Llovet J, Bru C, Bruix J . Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19(3):329-38. DOI: 10.1055/s-2007-1007122. View

16.

Shirabe K, Matsumata T, Adachi E, Maeda T, Shimada M, Taketomi A . Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?. Hepatogastroenterology. 1995; 42(6):923-30. View

17.

Takasaki K . Glissonean pedicle transection method for hepatic resection: a new concept of liver segmentation. J Hepatobiliary Pancreat Surg. 1999; 5(3):286-91. DOI: 10.1007/s005340050047. View

18.

Leung T, Tang A, Zee B, Lau W, Lai P, Leung K . Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer. 2002; 94(6):1760-9. DOI: 10.1002/cncr.10384. View

19.

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

20.

Belghiti J, Guevara O, Noun R, Saldinger P, Kianmanesh R . Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001; 193(1):109-11. DOI: 10.1016/s1072-7515(01)00909-7. View